Literature DB >> 17227206

Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).

Lalitagauri M Deshpande1, Ronald N Jones, Thomas R Fritsche, Helio S Sader.   

Abstract

Emergence and dissemination of Enterobacteriaceae isolates harboring carbapenemases in various geographic regions represents a significant threat to the management of nosocomial infections. Enterobacteriaceae isolates from the SENTRY Antimicrobial Surveillance Program (2000-2004) demonstrating decreased susceptibility to imipenem and meropenem (minimum inhibitory concentration [MIC], > or =2 mg/L) were evaluated for the production of metallo-beta-lactamases and serine carbapenemases using disk approximation and polymerase chain reaction (PCR) tests. Carbapenemase-producing strains were epidemiologically typed by automated riboprinting and pulsed-field gel electrophoresis (PFGE) to establish clonality. Among 37,557 Enterobacteriaceae (5 genus groups) evaluated, 119 (0.32%) had increased carbapenem MIC values, and a carbapenemase was identified in 51 (42.9%) of these strains. KPC-2 and KPC-3 were the most frequently occurring carbapenemases (24 isolates, 20.2%) in the United States and were detected in Klebsiella spp, Citrobacter spp., Enterobacter spp., and Serratia marcescens strains isolated in New York, Arkansas, and Virginia. SME-2-producing S. marcescens were isolated in the New York City area, Texas, and Ohio, while NMC-A was found in one E. cloacae strain from New York. In contrast, metallo-beta-lactamases were prevalent in Europe. IMP-1-producing E. cloacae (11 isolates) were detected in Turkey, while VIM-1-producing strains were found in Italy (Enterobacter spp.) and Greece (Klebsiella pneumoniae). Clonal dissemination of carbapenemase-producing strains was observed in several medical centers on both continents. The occurrence of carbapenemases in various Enterobacteriaceae remains rare but appears to be spreading geographically (not in Latin America), mainly with metallo-beta-lactamases being found in Mediterranean Europe and KPC enzymes in the New York City area.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17227206     DOI: 10.1089/mdr.2006.12.223

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  55 in total

1.  Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.

Authors:  Borum Suh; Il Kwon Bae; Juwon Kim; Seok Hoon Jeong; Dongeun Yong; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

2.  Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.

Authors:  Gaelle Cuzon; Thierry Naas; Marie Claude Demachy; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

3.  Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene.

Authors:  Rodrigo E Mendes; Jan M Bell; John D Turnidge; Qiwen Yang; Yunsong Yu; Ziyong Sun; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

4.  First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States.

Authors:  Shiri Navon-Venezia; Azita Leavitt; Mitchell J Schwaber; J Kamile Rasheed; Arjun Srinivasan; Jean B Patel; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

Review 5.  Resistance plasmid families in Enterobacteriaceae.

Authors:  Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

6.  Contribution of β-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae.

Authors:  Ying Zhang; Xiaofei Jiang; Yanyan Wang; Gang Li; Yueru Tian; Hong Liu; Fuqi Ai; Yiming Ma; Bei Wang; Feiyi Ruan; Kumar Rajakumar
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

7.  bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.

Authors:  Björn A Espedido; Sally R Partridge; Jonathan R Iredell
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

8.  First report of Klebsiella oxytoca strain coproducing KPC-2 and IMP-8 carbapenemases.

Authors:  Bin Li; Jing-Yong Sun; Qing-Zhong Liu; Li-Zhong Han; Xin-Hong Huang; Yu-Xing Ni
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

9.  Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Anne M Distler; Courtney Kasuboski; Magdalena Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

10.  Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae testing susceptible to cefepime by reference methods.

Authors:  Renata C Picão; Ronald N Jones; Rodrigo E Mendes; Mariana Castanheira
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.